Home » DoJ

DoJ

Apr 20, 2018

Biotheranostics Settles False Claims Allegations With DOJ for $2M

The DOJ alleged Biotheranosics promoted and performed its Breast Cancer Index test for  patients who had not been in remission for five years and who had not been taking tamoxifen.

May 15, 2017

OIG Tracking Fraud, Inappropriate Use Within Rapidly Growing Genetic Testing Industry

Premium

With data analytics and more specific billing codes, the government has improved its ability to identify medically unnecessary genetic testing and other fraudulent activity.

Jul 15, 2016

Oh, Wrong Rate

Columbia University settles a civil fraud lawsuit that said it improperly used its on-campus indirect cost rate when seeking reimbursement for more than 400 grants.

Dec 31, 2015

Pathway Genomics to Pay $4M to Settle Kickback Allegations

The US Department of Justice sued the company for paying doctors to perform its genomic tests, and then obtaining government reimbursements.

Nov 03, 2014

Bio-Rad Resolves Foreign Corruption Investigation; Will Pay $55M to SEC, DOJ

NEW YORK (GenomeWeb) — Bio-Rad Laboratories has resolved a US Securities and Exchange Commission investigation into its violation of the Foreign Corrupt Practices Act due to the company's subsidiaries having made improper payments to foreign officials in Russia, Vietnam, and Thailand in order to

Sep 30, 2014

US Investigation into Agilent's China Operations Concludes Without Actions

NEW YORK (GenomeWeb) – Agilent Technologies said in a regulatory document on Monday that an investigation by US regulators into possible infractions by the company's employees in China has ended without any enforcement actions by the agencies.

Sep 09, 2013

Agilent Investigating Possible Business Infractions in China; Discloses Additional 250 Layoffs

NEW YORK (GenomeWeb News) – Agilent Technologies has launched an investigation into activities of certain of its employees in China for possible infractions of US law, the company said in its Form 10-Q.

Apr 17, 2013

SCOTUS Justices Struggle to Draw Line between Isolated DNA, cDNA in Gene Patent Hearing

Premium

Originally published April 16.

Aug 22, 2012

Federal Circuit Judges Considered USPTO Policy, Industry Impact in Ruling on Myriad's Gene Patents

Premium

Originally published Aug. 20.

Jul 25, 2012

At Federal Circuit Hearing, Plaintiffs in Myriad Case Fight to Keep Gene Patentability Issue on the Table

Premium

Originally published July 20.

Pages

The Scan

When the Ailment You're Studying Becomes Personal

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

Irish Genomics Initiative Looks to Expand Into Scotland

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

Another Source of Data for 23andMe

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

This Week in PLOS

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.

What's Popular?

In DoJ

  1. Biotheranostics Settles False Claims Allegations With DOJ for $2M

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.